Dingcun Luo
Overview
Explore the profile of Dingcun Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu F, Lin X, Chen Y, Ge M, Pan T, Shi J, et al.
Int J Comput Assist Radiol Surg
. 2025 Feb;
PMID: 39955452
Objective: BRAF is the most common mutation found in thyroid cancer and is particularly associated with papillary thyroid carcinoma (PTC). Currently, genetic mutation detection relies on invasive procedures. This study...
2.
Chen Y, Pan G, Wu F, Zhang Y, Li Y, Luo D
Biomed Pharmacother
. 2025 Feb;
184:117867.
PMID: 39904645
No abstract available.
3.
Huang X, Huang K, Zhang Y, Zhou L, Wu F, Qian S, et al.
Gland Surg
. 2024 Dec;
13(11):2010-2022.
PMID: 39678408
Background: Thyroid surgery is a common surgical procedure for the treatment of thyroid diseases, such as thyroid nodules, thyroid cancer, and hyperthyroidism. Despite significant advancements in surgical techniques and perioperative...
4.
Song P, Pan G, Zhang Y, Ni Y, Wang Q, Shi J, et al.
Endocr Pract
. 2024 Dec;
31(3):373-379.
PMID: 39631664
Background: Thyroid cancer generally boasts a favorable prognosis; however, advanced and refractory cases exhibit aggressive characteristics and resistance to conventional therapies, necessitating the investigation of innovative treatment modalities. Immunotherapy, which...
5.
Huang K, Huang X, Qian S, Cai Y, Wu F, Luo D
Sci Rep
. 2024 Oct;
14(1):25538.
PMID: 39462100
The incidence of thyroid cancer (TC) is increasing annually worldwide, with a growing burden. This study aims to analyze temporal trends in the burden of TC by age and sex...
6.
Chen Y, Wang Q, Huang X, Zhang Y, Li Y, Ni T, et al.
Digit Health
. 2024 Oct;
10:20552076241288831.
PMID: 39381823
Background: The detection rate of thyroid nodules has witnessed a significant surge in recent years, triggering heightened public apprehension. Short video platforms such as TikTok and BiliBili have showed tremendous...
7.
Wang Q, Pan G, Zhang Y, Ni Y, Mu Y, Luo D
Hum Vaccin Immunother
. 2024 Sep;
20(1):2403170.
PMID: 39294892
Thyroid cancer is a common endocrine malignancy that poses considerable therapeutic challenges in treating anaplastic carcinoma and advanced aggressive disease. Immunotherapy has become a prominent strategy for cancer treatment, and...
8.
Song P, Zhang Q, Xu Z, Shi Y, Jing R, Luo D
Biomark Res
. 2024 Jul;
12(1):69.
PMID: 39039550
No abstract available.
9.
Cai Y, Zhao L, Zhang Y, Luo D
Gland Surg
. 2024 Jul;
13(6):1088-1096.
PMID: 39015725
Background And Objective: Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer, accounting for up to 85-90% of cases, with the best overall prognosis and mostly inert...
10.
Chen Y, Pan G, Wu F, Zhang Y, Li Y, Luo D
Biomed Pharmacother
. 2024 Jun;
177:116971.
PMID: 38901201
Thyroid cancer is a prevalent endocrine malignancy whose global incidence has risen over the past several decades. Ferroptosis, a regulated form of cell death distinguished by the excessive buildup of...